The FDA-approved maximum dose for weight loss (Wegovy) is 2.4 mg weekly, though clinical practice often caps therapeutic semaglutide at 1.0 to 2.0 mg weekly for compounded formulations
For tirzepatide, this historically meant preparing lyophilized vials or pre-mixed solutions at various concentrations, sometimes with added compounds like vitamin B12 , glycine , or niacinamide
IGF-1 LR3 is a modified analog of IGF-1 with a dramatically extended half-life (20-30 hours vs minutes) and enhanced potency
Buying a 3-month supply at once often comes with a per-unit discount
This article is part of the PlexusDx Education Hub, our library of evidence-based guidance on GLP-1 therapies, weight-management protocols, and the genetic variables behind every metabolic decision
Eli Lilly previously said that phase three study was expected to finish in February 2026